Literature DB >> 829923

Pharmacology of hypothalamic regulatory peptides.

W Vale, C Rivier, M Brown, J Leppaluoto, N Ling, M Monahan, J Rivier.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 829923     DOI： 10.1111/j.1365-2265.1976.tb03834.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.

Authors:  S Bajusz; T Janaky; V J Csernus; L Bokser; M Fekete; G Srkalovic; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.

Authors:  Manoj P Samant; Jozsef Gulyas; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

3.  Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.

Authors:  S Domschke; W Domschke; S R Bloom; P Mitznegg; S J Mitchell; G Lux; U Strunz
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

4.  Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog.

Authors:  J R Mathias; K L Ferguson; M H Clench
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

Review 5.  Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance.

Authors:  Jean E Rivier; Catherine L Rivier
Journal:  Front Neuroendocrinol       Date:  2013-11-20       Impact factor: 8.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.